Aethlon Medical, Inc.
AEMD
$1.71
-$0.10-5.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.85% | 6.63% | -35.71% | 15.60% | 71.83% |
| Total Depreciation and Amortization | 206.30% | -189.84% | -30.95% | 45.38% | 223.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.92% | 390.61% | 36,100.00% | -99.72% | -98.54% |
| Change in Net Operating Assets | -570.47% | 2.97% | 78.82% | -120.07% | 30.19% |
| Cash from Operations | -8.35% | 6.62% | -13.00% | 3.28% | -2.53% |
| Capital Expenditure | -338.10% | -23.53% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -338.10% | -23.53% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,904,100.00% | -100.00% | 6.97% | -- | -- |
| Repurchase of Common Stock | -350.00% | 16.67% | 63.64% | 38.89% | -86.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.77% | 80.85% | -- | -- | -- |
| Cash from Financing | 1,024.78% | -106.59% | -20.27% | 69,379.63% | -100.23% |
| Foreign Exchange rate Adjustments | -121.35% | 648.57% | -155.56% | 140.65% | -545.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.20% | -274.92% | -47.18% | 220.33% | -352.96% |